Breaking Federal Reserve Poised to Hold Interest Rates Steady Amid Inflation Worries Ex-Husband to Resume Testimony in Lindsay Clancy Murder Trial Magnitude 7.1 Earthquake Devastates Kumamoto Region, Claims Lives Delhi Aims for Electric Vehicle Transition by 2027 to Combat Pollution Supreme Court Won’t Reconsider Birthright Citizenship Ruling After Deadline Passes

Tuesday July 28, 2026

Reporter

UroGen Pharma Ltd.

3Articles Published

5Communities Covered

Published Articles

Press Release

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

Jul 15

Press Release

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

Jul 15

Press Release

UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

Jul 8